Drug Store News

Alvotech, Dr. Reddy’s collaborate for biosimilar candidate to Prolia, Xgeva

Dr. Reddy’s and Alvotech have entered into a license and supply agreement for the commercialization of AVT03, Alvotech’s biosimilar candidate to Prolia and Xgeva (denosumab). The collaboration ...
Business Wire

Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK

HYDERABAD, India & REYKJAVIK, Iceland--(BUSINESS WIRE)--Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ...
Yahoo Finance

European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®

REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, ...
FiercePharma

Amgen rolls new Prolia osteoporosis ads, just weeks after next-gen Evenity hits a snag

Amgen's new Prolia TV ad takes a familiar tack. It features a longtime spokesperson, actress Blythe Danner, and it re-ups the bone-strengthening message aimed at postmenopausal women. But the new ad ...